First AD

Second AD

Key Updates in Clinical Guidelines for CKD Testing in Patients With Type 2 Diabetes

What are the key updates in clinical guidelines for CKD testing in patients with type 2 diabetes?

Enhancing CKD Care in Type 2 Diabetes: Bridging Gaps in Diagnosis, Treatment, and Patient Outcomes

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Recent updates in clinical guidelines emphasize the importance of early and regular testing for chronic kidney disease (CKD) in patients with type 2 diabetes. These guidelines recommend using both estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) to assess kidney function and damage. The integration of these tests allows for a more comprehensive evaluation of kidney health, facilitating timely intervention. Additionally, the guidelines highlight the role of SGLT2 inhibitors and GLP-1 receptor agonists in managing CKD progression, underscoring their nephroprotective benefits.

Panelists discuss key updates in clinical guidelines for chronic kidney disease (CKD) testing in patients with type 2 diabetes, highlighting the latest recommendations for improving screening and diagnosis.